Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial

Nutrition Journal
Tatsuya OharaShinji Murosaki

Abstract

We have previously shown that a combination of glucosyl hesperidin (G-hesperidin) plus caffeine reduces accumulation of body fat, whereas G-hesperidin or caffeine alone shows little effect on high-fat diet-induced obesity in mice. The aim of this study is to evaluate the anti-obesity effect of G-hesperidin plus caffeine on body fat and serum TG in healthy subjects with moderately high body mass index (BMI) and serum TG. Since we considered that there are individual differences in caffeine sensitivity, we conducted dose-finding study of caffeine combined with G-hesperidin. Seventy-five healthy subjects with moderately high BMI (24-30 kg/m(2)) and serum TG (100-250 mg/dl) were divided and assigned to 12-week intervention with daily intakes of 500 mg of G-hesperidin with or without 25, 50, or 75 mg of caffeine, or placebo in a randomized double-blind placebo-controlled design . After intervention, decreases in abdominal fat area (AFA), especially subcutaneous fat area (SFA), were significantly greater in the G-hesperidin with 50-mg caffeine group (AFA:-8.4 ± 21.9 v.s. 16.3 ± 34.1 cm(2); p < 0.05, SFA: -9.3 ± 17.1 v.s. 11.2 ± 18.3 cm(2); p < 0.01) and in the G-hesperidin with 75-mg caffeine group (AFA:-17.0 ± 31.4 v.s. 16.3 ± 34.1 ...Continue Reading

References

Aug 1, 1978·The American Journal of Clinical Nutrition·H Correa, J Jacoby
Jul 1, 1992·Metabolism: Clinical and Experimental·A AstrupF Quaade
Jan 1, 1987·Psychopharmacology·H R LiebermanI L Coviella
May 1, 1988·American Journal of Epidemiology·M A DavisW W Hauck
Dec 1, 1984·The Journal of Physiology·P A Leijten, C van Breemen
Apr 29, 1993·The New England Journal of Medicine·T YoungS Badr
Nov 1, 2002·Epidemiology·Andrew S RowlandDale P Sandler
Dec 4, 2002·JAMA : the Journal of the American Medical Association·Hanna-Maaria LakkaJukka T Salonen
Jul 29, 2003·Journal of Nutritional Science and Vitaminology·Koutarou MuroyamaMasamitsu Miyoshi
Nov 19, 1953·The New England Journal of Medicine·G W MITCHELL, J ROGERS
Sep 25, 2004·Journal of Nutritional Science and Vitaminology·Yoshikatsu MiwaMasayoshi Kibata
Jul 15, 2006·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Kristel DiepvensMargriet S Westerterp-Plantenga
Sep 14, 2006·Journal of Nutritional Science and Vitaminology·Yoshikatsu MiwaMasayoshi Kibata
May 26, 2007·Stroke; a Journal of Cerebral Circulation·Toshiharu NinomiyaYutaka Kiyohara
Nov 6, 2008·American Journal of Physiology. Endocrinology and Metabolism·Lars C GormsenSøren Nielsen
Nov 13, 2009·The American Journal of Clinical Nutrition·Olivia J PhungCraig I Coleman
Sep 29, 2011·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·A E Jeukendrup, R Randell

❮ Previous
Next ❯

Citations

Jan 7, 2017·Biochimie·M Luisa BonetAndreu Palou
Jun 13, 2017·Frontiers in Psychiatry·Jennifer L TempleMiriam A Mestre
Apr 5, 2017·The Journal of Medical Investigation : JMI·Hitomi KobayashiTohru Sakai
Oct 21, 2018·BMC Pharmacology & Toxicology·Sabah AnsarSherifa S Hamed
May 23, 2018·Mediators of Inflammation·Lucrecia Carrera-QuintanarDaniel Ortuño-Sahagún
Oct 8, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Babalwa U JackCarmen Pheiffer

❮ Previous
Next ❯

Software Mentioned

Fat [UNK]
SAS
Excel

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.